Table 1A
Comparisons of demographic, clinical, and angiographic variables between elderly and the younger populations.
| VARIABLES | AGE GROUP ≥70 YEARS (N = 575) | AGE GROUP <70 YEARS (N = 3052) | P VALUE |
|---|---|---|---|
| Demographic and clinical variables | |||
| Women | 197 (34.3%) | 559 (18.3%) | <0.001 |
| Hypertension | 332 (57.7%) | 1248 (40.9%) | <0.001 |
| Diabetes mellitus | 277 (48.2%) | 1352 (44.3%) | 0.171 |
| Current smoker | 233 (40.5%) | 1964 (64.4%) | <0.001 |
| History of previous revascularization | 33 (5.7%) | 198 (6.5%) | 0.285 |
| Chronic kidney disease | 216 (37.6 %) | 250 (8.2%) | <0.001 |
| Killip class ≥II at presentation | 161 (28%) | 468 (15.3%) | <0.001 |
| Cardiogenic shock at presentation | 67 (11.7%) | 155 (5.1%) | <0.001 |
| Total Ischemic time (hours) Median, interquartile range | 6.4 (4.0–10) | 5.8 (3.7–9.2) | 0.007 |
| Radial access | 349 (60.7%) | 2143 (70.2%) | <0.001 |
| Angiographic variables | |||
| Associated severe LM disease | 33 (5.7%) | 95 (3.1%) | 0.001 |
| Proximal LAD culprit | 235 (40.9%) | 1158 (37.9%) | 0.77 |
| Non proximal LAD culprit | 135 (23.5%) | 802 (26.3%) | 0.057 |
| LCX lesion culprit | 82 (14.3%) | 516 (16.9%) | 0.204 |
| RCA lesion culprit | 199 (34.6%) | 851 (27.9%) | <0.001 |
| Ramus lesion culprit | 6 (1%) | 22 (0.7%) | 0.431 |
| Large thrombus burden | 92 (16.0%) | 578 (18.9%) | 0.194 |
| Final TIMI flow 0 or 1 | 6 (1.0%) | 27 (0.9%) | 0.694 |
| Other non-culprit vessel severe lesions | 232 (40.3%) | 936 (30.7%) | <0.001 |
Table 1B
Comparisons of demographic, clinical, and angiographic variables between the Octogenarians and Septuagenarians subgroups.
| VARIABLES | OCTOGENARIANS (≥80 YEARS)(N = 103) | SEPTUAGENARIANS (AGE OF 70–79 YEARS)(N = 472) | P VALUE |
|---|---|---|---|
| Demographic and clinical variables | |||
| Women | 32 (31.1%) | 165 (34.9%) | 0.493 |
| Hypertension | 61 (59.2%) | 274 (58.05%) | 0.857 |
| Diabetes mellitus | 48 (46.6%) | 232 (49.15%) | 0.790 |
| Current smoker | 39 (37.9%) | 196 (41.5%) | 0.516 |
| History of previous revascularization | 10 (9.7%) | 64 (13.6%) | 0.602 |
| Chronic kidney disease | 57 (55.34 %) | 161 (34.11%) | <0.001 |
| Killip class ≥II at presentation | 33 (32.03%) | 128 (27.11%) | 0.334 |
| Total-Ischemic time (hours) Median, interquartile range | 7 (4.5–10.6) | 6 (4.0–9.6) | 0.154 |
| Angiographic variables | |||
| Severe LM disease | 10 (9.7%) | 23 (4.9%) | 0.072 |
| Proximal LAD culprit | 38 (36.9%) | 197 (41.7%) | 0.582 |
| Non proximal LAD culprit | 22 (21.4%) | 113 (23.9%) | 0.847 |
| LCX lesion culprit | 17 (16.5%) | 65 (13.8%) | 0.759 |
| RCA lesion culprit | 39 (37.9%) | 160 (33.9%) | 0.712 |
| Ramus lesion culprit | 1 (1%) | 5 (1.1%) | 0.755 |
| Large thrombus burden | 17 (16.5%) | 75 (15.9%) | 0.679 |
| Final TIMI flow 0 or 1 | 2 (1.9%) | 4 (0.8%) | 0.077 |

Figure 1
Comparison of the incidence of in-hospital mortality between the three groups.
Table 2A
Comparison of in-hospital complications and outcomes between elderly and the younger populations.
| VARIABLES | AGE GROUP ≥70 YEARS (N= 575) | AGE GROUP <70 YEARS (N= 3052) | P VALUE |
|---|---|---|---|
| Contrast-induced nephropathy | 55 (9.6%) | 100 (3.3%) | <0.001 |
| Stroke | 3 (0.5%) | 9 (0.3%) | 0.581 |
| TIMI major bleeding | 10 (1.7%) | 26 (0.9%) | 0.027 |
| • Vascular access-related | 2 (20% of major bleeding) | 2 (7.7% of major bleeding) | |
| • Non-Vascular access-related | 8 (80% of major bleeding) | 24 (92.3% of major bleeding) | |
| Intracranial hemorrhage | 4 (0.7%) | 8 (0.3%) | 0.092 |
| Acute and subacute Stent thrombosis | 6 (1.0%) | 13 (0.4%) | 0.036 |
| In-hospital mortality | 81 (14.1%) | 122 (4%) | <0.001 |
Table 2B
Comparisons of in-hospital complications and outcomes between Octogenarians and Septuagenarians subgroups.
| VARIABLES | OCTOGENARIANS (≥80 YEARS) (N = 103) | SEPTUAGENARIANS (70–79 YEARS) (N = 472) | PVALUE |
|---|---|---|---|
| Contrast-induced nephropathy | 13 (12.6%) | 42 (8.9%) | 0.267 |
| Stroke | 1 (1%) | 2 (0.4%) | 0.149 |
| TIMI major bleeding | 2 (1.9%) | 8 (1.7%) | 0.696 |
| Intracranial hemorrhage | 1 (1%) | 3 (0.6%) | 0.629 |
| Acute and subacute Stent thrombosis | 2 (1.9%) | 8 (1.7%) | 0.777 |
| In hospital mortality | 24 (23.3%) | 57 (12.1%) | 0.005 |
Table 3A
Table 3A Predictors of in-hospital mortality among the Elderly cohort (multivariate analysis).
| VARIABLES | OR (95% CI) | P VALUE |
|---|---|---|
| Sex | 0.915 (0.540–1.549) | 0.740 |
| Age ≥ 80 years | 2.317 (1.303–4.120) | 0.004 |
| Diabetes Mellitus | 1.608 (0.947–2.730) | 0.079 |
| Hypertension | 1.550 (0.902–2.664) | 0.113 |
| CKD | 0.991 (0.592–1.659) | 0.971 |
| History of previous revascularization | 0.284 (0.062–1.297) | 0.104 |
| Killip class ≥II at presentation | 4.568 (2.760–7.560) | <0.001 |
Table 3B
Factors associated with in-hospital mortality stratified by age groups (multivariate analysis).
| VARIABLES | OCTOGENARIANS (≥80 YEARS) (n = 103) | SEPTUAGENARIANS (70–79 YEARS) (n = 472) | AGE GROUP <70 YEARS (n = 3052) | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| Sex | 0.86 (0.269–2.79) | 0.812 | 1.6 (0.75–3.3) | 0.26 | 1.42 (0.8–2.4) | 0.635 |
| Diabetes Mellitus | 2.3 (0.820–6.73) | 0.112 | 0.64 (0.33–1.4) | 0.17 | 1.87 (1.26–2.93) | 0.004 |
| Hypertension | 1.1 (0.372–3.230) | 0.868 | 0223–0.843 | 0.14 | 0.94 (0.6–14) | 0.790 |
| Current smoker | 1.6 (0.531–5.33) | 0.373 | 0.370–1.272 | 0.231 | 0.87 (0.5–1.4) | 0.598 |
| History of previous revascularization | 0.86 (0.297–45) | 0.312 | 0.582–35.503 | 0.149 | 1.7 (0.7–40) | 0.234 |
| Killip class ≥II at presentation | 6.57 (2.19–19.7) | 0.001 | 0.136–0.441 | 0.001 | 7.4 (5–10.9) | <0.001 |
| Chronic kidney disease | 0.52 (0.181–1.56) | 0.251 | 0.580–1.979 | 0.826 | 2.6 (1.6–4.1) | <0.001 |
Table 4
Factors associated with TIMI major bleeding in the elderly (univariate analysis).
| VARIABLES | TIMI MAJOR BLEEDING (N = 10) | NO TIMI MAJOR BLEEDING (N = 565) | P VALUE |
|---|---|---|---|
| Age ≥ 80 years | 2 (20%) | 101 (17.9%) | 0.560 |
| Female gender | 4 (40%) | 193 (34.2%) | 0.446 |
| Hypertension | 7 (70%) | 325 (57.5%) | 0.539 |
| Diabetes Mellitus | 6 (60%) | 271 (48%) | 0.541 |
| CKD | 4 (40%) | 212 (37.5%) | 0.556 |
| Glycoprotein IIb/IIIa inhibitors | 4 (40%) | 87 (15.4%) | 0.139 |
| Femoral access | 9 (90%) | 217 (38.4%) | 0.001 |
